Mayr F, Kruse V, Fuhrmann DC, Wolf S, Löber J, Alsouri S, Paglilla N, Lee K, Chapuy B, Brüne B, Zenz T, Häupl B, Oellerich T, Engelke M (2024). SH2 domain-containing inositol 5-phosphatases support the survival of Burkitt lymphoma cells by promoting energy metabolism. Haematologica. May 1;109(5):1445-1459. doi: 10.3324/haematol.2023.283663.

Alsouri S, Ambrose A, Mougios N, Paglilla N, Mayr F, Choi K, Loeber J, Chapuy B, Haeupl B, Opazo F, Oellerich T, Gold M, Engelke M (2024). Actinin-4 controls survival signaling in B cells by limiting the lateral mobility of B-cell antigen receptors. Eur J Immunol. 2024 Mar;54(3):e2350774. doi: 10.1002/eji.202350774.

Sieme D, Engelke M, Rezaei-Ghaleh N, Becker S, Wienands J, Griesinger C (2024). Autoinhibition in the Signal Transducer CIN85 Modulates B Cell Activation. J Am Chem Soc. Jan 10;146(1):399-409. doi: 10.1021/jacs.3c09586.

Wilke AC, Doebele C, Zindel A, Lee KS, Rieke SA, Ceribelli M, Comoglio F, Phelan JD, Wang JQ, Pikman Y, Jahn D, Häupl B, Schneider C, Scheich S, Tosto FA, Bohnenberger H, Stauder P, Schnütgen F, Slabicki M, Coulibaly ZA, Wolf S, Bojarczuk K, Chapuy B, Brandts CH, Stroebel P, Lewis CA, Engelke M, Xu X, Kim H, Dang TH, Schmitz R, Hodson DJ, Stegmaier K, Urlaub H, Serve H, Schmitt CA, Kreuz F, Knittel G, Rabinowitz JD, Reinhardt HC, Vander Heiden MG, Thomas C, Staudt LM, Zenz T, Oellerich T (2022). SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma. Blood. Jan 27;139(4):538-553. doi: 10.1182/blood.2021012081.

Gayer, F.A., Reichardt, S.D., Bohnenberger, H., Engelke, M., and Reichardt H.M. (2022). Characterization of testicular macrophage subpopulations in mice. Immunology Letters 243, 44-52.
Wong LE, Bhatt A, Erdmann PS, Hou Z, Maier J, Pirkuliyeva S, Engelke M, Becker S, Plitzko J, Wienands J, Griesinger C (2020). Tripartite phase separation of two signal effectors with vesicles priming B cell responsiveness. Nat Commun. 2020 Feb 12;11(1):848. doi: 10.1038/s41467-020-14544-1.

Kaiser, T.K., Khorenko, M., Moussavi, A., Engelke, M., Boretius, S., Feldmann, C., and Reichardt, H.M. (2020). Highly selective organ distribution and cellular uptake of inorganic-organic hybrid nanoparticles customized for the targeted delivery of glucocorticoids. J Control Release 319: 360-370.

Walter R, Pan KT, Doebele C, Comoglio F, Tomska K, Bohnenberger H, Young RM, Jacobs L, Keller U, Bönig H, Engelke M, Rosenwald A, Urlaub H, Staudt LM, Serve H, Zenz T, Oellerich T (2017). HSP90 promotes Burkitt lymphoma cell survival by maintaining tonic B-cell receptor signaling. Blood. Feb 2;129(5):598-608.

Manno B, Oellerich T, Schnyder T, Corso J, Lösing M, Neumann K, Urlaub H, Batista FD, Engelke M*, and Wienands J* (2016). The Dok-3/Grb2 adaptor module promotes inducible association of the lipid phosphatase SHIP with the BZR in a coreceptor-independent manner. European Journal of Immunology. Nov;46(11):2520-2530. *corresponding authors

Corso J., Pan K.T., Walter R., Doebele C., Mohr S., Bohnenberger H., Ströbel P., Lenz C., Slabicki M., Rieger M., Engelke M., Wienands J., Zenz T., Serve H., Urlaub H., Oellerich T. (2016). Elucidation of tonic and activated B cell receptor signaling in Burkitt’s lymphoma provides insights into regulation of cell survival. Proc Natl Acad of Sci USA, 7;113(20):5688-93.

Isernhagen, A., Malzahn, D., Viktorova, E., Elsner, L., Monecke, S., von Bonin, F., Kilisch, M., Wermuth, J.M., Walther, N., Balavarca, Y., Stahl-Hennig, C., Engelke, M., Walter, L., Bickeboller, H., Kube, D., Wulf, G., and Dressel, R. (2015). The MICA-129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantation. EMBO Mol Med 7(11): 1480-1502.